Skip to main content
Everfront Biotech Holding Company Limited (EFB)
Everfront Biotech Holding Company will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet

EFB Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year Ending
 TTM Dec '23 Dec '22
Net Income
-2.13-2.29-1.49
Depreciation & Amortization
0.040.040.04
Other Operating Activities
0.22-0.03-0.47
Operating Cash Flow
-1.87-2.28-1.92
Capital Expenditures
-0-0.03-
Change in Investments
---0
Other Investing Activities
-0.01-0.01-0
Investing Cash Flow
-0.01-0.04-0
Debt Issued / Paid
-2.510.3
Other Financing Activities
2.120.52.16
Financing Cash Flow
2.123.012.46
Net Cash Flow
0.220.670.52
Free Cash Flow
-1.87-2.31-1.92
Free Cash Flow Margin
---2407.77%
Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).